Cellestial Health joins forces with o2h in drug discovery as an awardee of the latest Kickstrater Award.
o2h discovery is a collaborative Contract Research Organisation which has an integrated drug discovery platform in Ahmedabad (India) and Cambridge (UK). o2h offer a multi-modality integrated drug discovery platform to support their collaborators developing the next generation of therapies. For more information about o2h discovery, please visit https://o2hdiscovery.co/
Launched in August 2022, the o2h Kickstarter Award empowers select early-stage startups with a chemistry boost for their small molecules and complex drug discovery projects. With over 7+ successful editions, o2h proudly supported 27+ innovative biotech startups worldwide, accelerating novel drug development programs that have the potential to impact human health and the environment. Learn more about the o2h Kickstarter Award: https://o2h.com/the-o2h-kickstarter-competition/
Cellestial Health looks forward to this partnership to advance its pipeline of safe, brain-permeable small molecule therapeutics to slow down or stop the progression of Parkinson’s and other neurological conditions from the time of diagnosis.
